| Aleshia Danielle Palmer Johnson, | |
|
829 Tulip Poplar Dr, Hoover, AL 35244-1639 | |
| (205) 531-9215 | |
| Not Available |
| Full Name | Aleshia Danielle Palmer Johnson |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Neonatal Intensive Care |
| Location | 829 Tulip Poplar Dr, Hoover, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174127096 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WN0002X | Registered Nurse - Neonatal Intensive Care | 1-155310 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Aleshia Danielle Palmer Johnson, 829 Tulip Poplar Dr, Hoover, AL 35244-1639 Ph: (205) 531-9215 | Aleshia Danielle Palmer Johnson, 829 Tulip Poplar Dr, Hoover, AL 35244-1639 Ph: (205) 531-9215 |
News Archive
According to trials, a new obesity drug, Tesofensine, which may be launched on the world market in a few years, can produce weight loss twice that of currently approved obesity drugs. The Danish company Neurosearch and a number of researchers at the Faculty of Life Sciences at University of Copenhagen are behind the promising findings.
The Bristol-Myers Squibb Foundation today awarded five grants totaling $1.5 million to organizations that will empower African American women with type 2 diabetes to better manage their disease while also leveraging their standing as leaders in their families and communities to influence the health of those around them.
Symphogen A/S today announced that it has initiated a Phase 1/2 human clinical trial in the US to evaluate the safety, tolerability and efficacy of its drug candidate Sym004 for the treatment of advanced solid tumors. Sym004 is composed of two anti-epidermal growth factor receptor monoclonal antibodies targeting different nonoverlapping EGFR epitopes.
IpAuctions™ has scheduled a live international corporate sale of the extensive IP portfolio of pouchless ostomy management technologies owned by Zassi Holdings, Inc. Zassi, the Florida-based firm, fosters breakthrough medical devices that are materially evolving the life sciences industry.
A new study offers the first evidence that a protein named BAM15 acts as an energy uncoupler and could be an effective drug for treating obesity and related diseases.
› Verified 4 days ago
Emme Lane Novoa, FNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 1849 Data Dr Ste 1, Hoover, AL 35244 Phone: 205-774-8222 | |
Mrs. Thara Babu Nair, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 719 Crowne Reserve Dr, Hoover, AL 35244 Phone: 517-775-9955 | |
Kannika Green, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10 Meadowview Dr, Hoover, AL 35242 Phone: 205-547-2323 | |
Yvonne Renta, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 825 Mill Springs Pl, Hoover, AL 35244 Phone: 205-566-6233 | |
Rachel M Mendonca-hasenbein, MSN, CRNP, PMHNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 3000 Riverchase Galleria Ste 500, Hoover, AL 35244 Phone: 205-994-8811 | |
Ashley Wear, CRNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2111 Parkway Office Cir Ste 150, Hoover, AL 35244 Phone: 205-364-2347 | |
Joel Nicolas Rocha, BSN RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1012 Lake Heather Reserve # 1012, Hoover, AL 35242 Phone: 334-447-9865 |